Pacific Biosciences Of California (PACB) Cash from Operations (2010 - 2026)

Pacific Biosciences Of California's Cash from Operations history runs 17 years deep, the most recent figure standing at 44691000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 1.44% year-over-year to 44691000.0; the TTM figure through Mar 2026 stood at 111844000.0 (up 35.88% YoY), while the FY2025 annual figure was 111209000.0, up 46.03% from the prior year.
• Cash from Operations was 44691000.0 for Q1 2026 at Pacific Biosciences Of California, down from 19069000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 18707000.0 in Q3 2025 to a low of 94691000.0 in Q1 2023.
• Historically, Cash from Operations has averaged 52020117.65 across 5 years, with a median of 54263000.0 in 2024.
• The sharpest annual moves came in 2022 and 2025: Cash from Operations plunged 285.46% in 2022, then jumped 58.85% in 2025.
• A 5-year view of Cash from Operations shows it stood at 60566000.0 in 2022, then grew by 4.96% to 57560000.0 in 2023, then jumped by 46.75% to 30650000.0 in 2024, then jumped by 37.78% to 19069000.0 in 2025, then slumped by 134.36% to 44691000.0 in 2026.
• The last three Cash from Operations figures came in at 44691000.0 (Q1 2026), 19069000.0 (Q4 2025), and 18707000.0 (Q3 2025), per Business Quant data.